Associated Papers
The pharmacogenetics of tacrolimus in renal transplant patients: association with tremors, new-onset diabetes and other clinical events.
Abderahmene A et al.
The Pharmacogenomics Journal, 2024
Overexpression of P-glycoprotein and MRP-1 are pharmacogenomic biomarkers to determine steroid resistant phenotype in childhood idiopathic nephrotic syndrome.
Prasad N et al.
The Pharmacogenomics Journal, 2021
Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics.
Koller D et al.
Advances in Therapy, 2021
33278020 (PubMed )
Supplement: 12325_2020_1566_MOESM1_ESM.docx
Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug.
Zhao W et al.
British Journal of Clinical Pharmacology, 2018
MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children.
Jafar T et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 2011
MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children.
Wasilewska A et al.
Pediatric Nephrology (berlin, Germany), 2007
Select a paper to view details